We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tumor Defense System Discovered

By Biotechdaily staff writers
Posted on 23 Aug 2005
Scientists have found that tumors discharge fatty acids that interfere with the cells that are trying to destroy them. More...
As a result, new strategies that decrease the amount of fatty acids around the tumors may provide new approaches to anticancer treatment.

Several types of anticancer therapy are based on immunotherapeutic anti-cancer strategies, therapies that boost the body's immune system, such as cytotoxic T lymphocytes, to help destroy tumors. However, immunotherapeutic techniques are frequently not effective at removing established tumors for a variety of reasons including a loss of the ability of the cytotoxic T lymphocytes to recognize the tumor and a physical barrier separating the tumor and the lymphocytes.

Now, researchers from the Torrey Pines Institute for Molecular Studies (San Diego, CA, USA) have added another reason to this inventory. They found that tumors secrete fatty acids which suppress the cytotoxic T lymphocytes' ability to destroy tumor cells. Their findings were published in the September 2005 issue of the Journal of Lipid Research.

"We found two things,” explained Dr. Alan M. Kleinfeld. "First, the most common type of free fatty acids, which at normal levels are essential for life, at high levels prevents the cytotoxic T lymphocytes from destroying tumor cells. The second thing is that human breast cancer cells, but not normal tissue from the same breast, produce very large amounts of the type of free fatty acids that block the cytotoxic T lymphocytes. Thus, the cancer may have a way of defending itself against attack by the immune system, thereby reducing the potential efficacy of novel anti-cancer therapies that rely on a functioning immune system.”

The free fatty acids work against cytotoxic T lymphocytes by inhibiting a number of the lymphocytes' signaling processes. For example, they keep specific proteins from being phosphorylated and they also prevent an increase in intracellular calcium that is vital for the cytotoxic T lymphocytes to destroy the tumor cells. Dr. Kleinfeld believes that these signaling mechanisms are being blocked at the cells' membranes.

These findings raise the possibilities of new therapeutic targets for cancer, such as those that may move free fatty acids out of the tumor. Furthermore, free fatty acid levels in the blood could be utilized to help evaluate the aggressive potential of a tumor.






Related Links:
Torrey Pines Institute for Molecular Studies

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Clinical Informatics Platform
CLARION™
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.